Press-release for stocks published on this month related to events

Prices are updated after-hours

published : This month tags : Events

save search

Two Clinical Trials Identify a Better Way to Target Appropriate Antibiotics for Patients Hospitalized With Pneumonia or Urinary Tract Infection
Published: 2024-04-19 (Just crawled : 22:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320

Communications

| Email alert Add to watchlist
infection antibiotics trials for

Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
Published: 2024-04-19 (Crawled : 14:00) - biospace.com/
OM | $2.33 3.56% 3.43% 830K

Health Technology

| 0.0% | O: 2.78% H: 0.0% C: 0.0%
first report medical financial results

Henry Schein Supports The ‘Carry The Load’ Memorial May Campaign For Third Consecutive Year
Published: 2024-04-18 (Crawled : 12:00) - biospace.com/
HSIC | News | $70.87 1.29% 1.27% 770K

Distribution Services

| -2.7% | O: -2.7% H: 0.0% C: 0.0%
year for

Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024
Published: 2024-04-18 (Crawled : 12:00) - biospace.com/
ALDX | News | $3.865 -2.89% -2.98% 430K

Health Technology

| 1.79% | O: 1.53% H: 2.52% C: 0.25%
day research therapeutics development

Establishment Labs Announces Participation in The Aesthetic Meeting 2024
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
ESTA | $47.425 -9.79% -10.85% 430K

Health Technology

| 0.79% | O: 0.79% H: 0.0% C: 0.0%
aesthetic meeting

Mirion Announces Earnings Release and Conference Call Date for First Quarter 2024
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
MIR | $10.98 1.67% 0.0% 1.5M

| 1.44% | O: 0.96% H: 1.71% C: 0.48%
first conference for

Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
NVRO | $12.07 -2.03% 0.0% 390K

Health Technology

| -3.23% | O: -0.55% H: 0.16% C: -2.69%
conference report financial results

Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
EVGN | $0.7 -13.64% 63K

Health Technology

| Email alert Add to watchlist
meeting

Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
VCYT | $19.43 1.2% 1.18% 1.4M

Health Technology

| -0.88% | O: -0.93% H: 0.0% C: -1.41%
bladder

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
UTHR | $237.99 0.45% 0.45% 400K

Health Technology

| 0.1% | O: -0.41% H: 0.0% C: -1.0%
conference international commercial therapeutics

Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
TARO | $42.25 0.14% 0.0% 17K

Health Technology

| 0.48% | O: 0.19% H: 0.28% C: 0.0%
approval for meeting

Can-Fite: Scientific Article Published by KOL Presents Namodenoson as a Promising Drug Candidate to Treat Advanced Liver Cancer and MASH
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K

Health Technology

| -6.19% | O: 4.76% H: 0.45% C: -5.91%
drug candidate liver cancer treat namodenoson advanced

Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
VTRS | $11.25 1.17% 1.16% 4.7M

Health Technology

| -3.89% | O: -0.17% H: 0.17% C: -1.9%
RVNC | $3.77 -0.53% -0.53% 1.6M

Health Technology

| -16.07% | O: -2.01% H: 1.37% C: -5.92%
daxxify neurology meeting

AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
ABBV | News | $166.41 1.06% 0.0% 5.5M

Health Technology

| -1.41% | O: -1.92% H: 0.0% C: 0.0%
qulipta abbvie treatment for migraine

Oncocyte Reports Full Year 2023 Financial ResultsConference Call on Friday, April 12, 2024 at 5:00 a.m. PT / 8:00 a.m. ET
Published: 2024-04-12 (Crawled : 11:00) - biospace.com/
BIO | News | $279.73 -0.46% 0.0% 290K

Health Technology

| -16.32% | O: -5.2% H: 0.24% C: -2.79%
OCX J | $2.495 -2.54% -2.61% 50K

Health Technology

| -12.65% | O: 7.93% H: 3.12% C: -15.31%
year financial

Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography
Published: 2024-04-11 (Crawled : 19:00) - biospace.com/
HOLX | $75.37 0.36% 0.36% 1.3M

Health Technology

| -3.47% | O: 0.73% H: 0.09% C: -0.51%

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
Published: 2024-04-11 (Crawled : 19:00) - biospace.com/
EDSA | $4.47 2.52% 2.46% 2.4K

Health Technology

| -6.94% | O: -3.95% H: 0.0% C: -0.44%
conference biotech

Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Published: 2024-04-10 (Crawled : 13:00) - biospace.com/
CYBN | News | $0.3677 -0.6% 0.35% 1.8M

n/a

| -13.06% | O: -1.96% H: 0.0% C: -4.65%
conference